Colistin resistance: a major breach in our last line of defence

David L. Paterson(The University of Queensland), Patrick N. A. Harris(The University of Queensland)

The Lancet Infectious Diseases

November 18, 2015

10.1016/s1473-3099(15)00463-6

Cited by 206

Related Papers

Antimicrobial Resistance in ESKAPE Pathogens

|Clinical Microbiology Reviews|2020|2k

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance

|JAMA|2018|761

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

|The Lancet Infectious Diseases|2017|521

The emerging threat of multidrug-resistant Gram-negative bacteria in urology

|Nature Reviews Urology|2015|367

Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study

|The Lancet Infectious Diseases|2021|338